Cargando…
Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia
BACKGROUND: Isolated methylmalonic acidemia/aciduria (MMA) is an ultra-rare, serious, inherited metabolic disorder with significant morbidity and mortality. Exogenously delivered mRNA encoding human methylmalonyl-CoA mutase (hMUT), the enzyme most frequently mutated in MMA, is a potential therapy to...
Autores principales: | An, Ding, Frassetto, Andrea, Jacquinet, Eric, Eybye, Marianne, Milano, Joseph, DeAntonis, Christine, Nguyen, Vi, Laureano, Rodrigo, Milton, Jaclyn, Sabnis, Staci, Lukacs, Christine M., Guey, Lin T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642332/ https://www.ncbi.nlm.nih.gov/pubmed/31303505 http://dx.doi.org/10.1016/j.ebiom.2019.07.003 |
Ejemplares similares
-
Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia
por: An, Ding, et al.
Publicado: (2017) -
Dual mRNA therapy restores metabolic function in long-term studies in mice with propionic acidemia
por: Jiang, Lei, et al.
Publicado: (2020) -
Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency
por: Almási, Tímea, et al.
Publicado: (2019) -
Methylmalonic acidemia: Neurodevelopment and neuroimaging
por: Chen, Tao, et al.
Publicado: (2023) -
Association of Methylmalonic Acidemia and Erythema Nodosum
por: Karamizadeh, Zohre, et al.
Publicado: (2011)